A randomized trial comparing peak expiratory flow versus symptom self-management plans for children with persistent asthma

Pediatric Asthma, Allergy and Immunology

Volumn 17, Issue 3, 2004, Pages 177-190

  Letz, K L ^a,b   Schlie, A R ^b   Smits, W L ^b  

^a UNIVERSITY OF PHOENIX   (United States)

^b Allergy and Asthma Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HEALTH CARE PLANNING; HUMAN; MALE; MEDICAL ASSESSMENT; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

EID: 7244223240     PISSN: 08831874     EISSN: None     Source Type: Journal    
DOI: 10.1089/pai.2004.17.177     Document Type: Article

References (38)

1. United States Center for Disease Control and Prevention. Surveillance for Asthma. MMWR. 1998; 47:1-28.
2. Weinberger, M. Asthma management: guidelines for the primary care physician. Medscape Respiratory Care, 1999. (Available online at http//www.medscape.com/medscape/r).
3. National Asthma Education and Prevention Program. Expert Panel Report II. Guidelines for the Diagnosis and Management of Asthma. Publication 97-4051. Bethesda, MD: National Institutes of Health; 1997.
4. Robertson CF, Rubinfield AR, Bowes G. Pediatric asthma deaths in Victoria: the mild are at risk. Pediatr Pulmonol 1992; 13:95-100.
5. National Heart, Lung, and Blood Institute (NHLBI). National Asthma Education Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma. J Allergy Clin Immunol. 1991; 88:425-534.
6. Cote J, Cartier A, Malo JL, Rouleau M, Boulet LP. Adherence with peak expiratory flow monitoring in home management of asthma. Chest 1998; 113:968-972.
7. Li JTC, O'Connell E. Clinical evaluation of asthma. Ann Allergy Asthma Immunol 1996; 76:1-14.
8. Kickuchi Y, Okabe S, Tamura G, et al. Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. N Engl J Med 1994; 330:1329-1334.
9. Apter A, Affleck G, Reisine S, et al. Perception of airway obstruction in asthma: sequential daily analyses of symptoms, peak expiratory flow rate, and mood. J Allergy Clin Immunol 1997; 99:605-612.
10. Berube D, Cartier A, L'archeveque J, et al. Comparison of peak expiratory flow rate and FEV1 in assessing bronchomotor tone after challenges with occupational sensitizers. Chest 1991; 99:831-836.
11. 1 in the monitoring of asthmatic subjects at an outpatient clinic. Chest 1994; 106:1419-1426.
12. National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma: expert panel report. Clinical Practice Guidelines. Publication 92-3091. Bethesda, MD: National Institutes of Health, 1991.
13. British Thoracic Society (BTS). 1993. Guidelines on the management of asthma. Thorax 1993; 48(suppl):1-24.
14. Weinstein AG. Clinical management strategies to maintain drug adherence in asthmatic children. Ann Allergy Asthma Immunol 1995; 74:304-310.
15. Creer T. Medication Adherence and Childhood Asthma. In NA Krasnegor, L Epstein, SB Johnson, SJ Yaffe, eds. Developmental aspects of health adherence behavior. Hillsdale, NJ: Lawrence Erlbaum Associates, 1993, pp. 303-333.
16. Coutts JA, Gibson NA, Paton JY. Measuring adherence with inhaled medication in asthma. Arch Dis Child 1992; 67:332-333.
17. Zora J, Lutz C, Tinkelman D. Assessment of adherence in children using inhaled beta adrenergic agonists. Ann Allergy 1989; 62:406-409.
18. Haynes R. Adherence in healthcare. Baltimore, MD: Johns Hopkins University Press, 1979.
19. rd ed. Philadelphia: W.B. Saunders, 1997.
20. National Asthma Education and Prevention Program. Expert panel report II. Guidelines for the diagnosis and management of asthma. Publication 97-4051. Bethesda, MD: National Institutes of Health, 1997.
21. Clough J, Sly P. Association between lower respiratory tract symptoms and falls in peak expiratory flow in children. Eur Respir J 1995; 8:718-722.
22. Woolcock A, Yan K, Salome C. Effect of therapy on bronchial hyperresponsiveness in the long-term management of asthma. Clin Allergy 1988; 18:165-176.
23. Beasley R, Cushley M, Holgate S. A self-management plan in the treatment of adult asthma. Thorax 1989; 44:200-204.
24. Clark N, Evans D, Mellins R. Patient use of peak flow monitoring. Am Rev Respir Dis 1992; 145:722-725.
25. nd ed. Philadelphia: Lippinicott, 1993.
26. 1 in the monitoring of asthmatic subjects at an outpatient clinic. Chest 1994; 106:1419-1426.
27. Creer T. Medication adherence in chronically ill children. Tijdschr Kindergeneeskd 1998; 66:141-145.
28. Turner M, Grump G, Contrearas R, Fitzgerald M. The challenge of delivering asthma education to a high risk group. Am J Respir Crit Care Med 1994; 149:251.
29. Leickly F. Barriers pediatricians face when using asthma guidelines. Pediatrics 2001; 108:551.
30. Coutts JA, Gibson NA, Paton JY. Measuring adherence with inhaled medication in asthma. Arch Dis Child 1992; 67:332-333.
31. Tashkin D. Multiple dose regimens: impact on adherence. Chest 1995; 107(suppl):176-182.
32. Rand CS, Wise RA. Adherence with asthma therapy in the management of asthma: review and clinical guidelines. In SJ Szefler, DYM Leung, eds. Severe asthma: pathogenesis and clinical management. New York: Marcel Dekker, 1996, pp. 434-464.
33. Baciewicz A, Kyllonen K. Aerosol inhaler technique in children with asthma. Am J Hosp Pharm 1989; 46:2510-2511.
34. Pederson S. Ensuring adherence in children. Eur Respir J 1992; 5:143-145.
35. DeBlaquiere P, Christensen D, Carter W, Martin T. Use and misuse of metered-dose inhalers by patients with chronic lung disease. Am Rev Respir Dis 1989; 140:910-916.
36. Crompton G. The adult patient's difficulty with inhalers. Lung 1990; 168:658-662.
37. Kaplan S, Greenfield S, Dukes K, et al. Effect of joint physician-patient training program on health outcomes and interpersonal care. Clin Res 1993; 41:541A.
38. Greenfield S, Kaplan S, Ware J, et al. Patients' participation in medical care. J Gen Intern Med 1988; 3:448-457.